var singsData = [{"date":new Date(2012,10,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pivotal Research initiates coverage on NLSN. Target Price is $31.","showOnAxis":true},{"date":new Date(2012,11,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $41; previously $36.","showOnAxis":true},{"date":new Date(2012,2,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains NLSN to Overweight. Target Price is $37; previously $34.","showOnAxis":true},{"date":new Date(2012,3,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2012 Q1's earning $0.07 per share and revenue $1334MM..","showOnAxis":false},{"date":new Date(2012,6,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"PiperJaffray maintains NLSN to Neutral. Target Price is $26; previously $28.","showOnAxis":true},{"date":new Date(2012,6,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2012 Q2's earning $0.42 per share and revenue $1390MM. This beats analyst's estimated EPS $0.41, misses estimated revenue $1400MM.","showOnAxis":false},{"date":new Date(2012,7,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains NLSN to Buy. Target Price is $35; previously $33.","showOnAxis":true},{"date":new Date(2012,9,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains NLSN to Buy. Target Price is $36; previously $35.","showOnAxis":true},{"date":new Date(2012,9,22),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2012 Q3's earning $0.29 per share and revenue $1351MM..","showOnAxis":false},{"date":new Date(2012,9,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $36; previously $35.","showOnAxis":true},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pivotal Research maintains NLSN to Hold. Target Price is $33; previously $31.","showOnAxis":true},{"date":new Date(2013,1,11),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"After market close, NLSN reports 2012 Q4's earning $0.62 per share and revenue $1460MM. This beats analyst's estimated EPS $0.59, misses estimated revenue $1480MM.","showOnAxis":false},{"date":new Date(2013,1,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains NLSN to Buy. Target Price is $38; previously $35.","showOnAxis":true},{"date":new Date(2013,1,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains NLSN to Outperform. Target Price is $38; previously $35.","showOnAxis":true},{"date":new Date(2013,1,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Benchmark maintains NLSN to Buy. Target Price is $38; previously $36.","showOnAxis":true},{"date":new Date(2013,10,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.2","showOnAxis":true},{"date":new Date(2013,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse initiates coverage on NLSN to Outperform. Target Price is $52.","showOnAxis":true},{"date":new Date(2013,11,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains NLSN to Buy. Target Price is $49; previously $42.","showOnAxis":true},{"date":new Date(2013,11,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital downgrades NLSN to Market Perform from Outperform. Target Price is $45; previously $43.","showOnAxis":true},{"date":new Date(2013,2,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.16","showOnAxis":true},{"date":new Date(2013,3,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital initiates coverage on NLSN to Outperform. Target Price is $41.","showOnAxis":true},{"date":new Date(2013,3,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2013 Q1's earning $0.38 per share and revenue $1380MM. This beats analyst's estimated EPS $0.36, misses estimated revenue $1400MM.","showOnAxis":false},{"date":new Date(2013,3,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Northland Securities initiates coverage on NLSN to Underperform. Target Price is $28.","showOnAxis":true},{"date":new Date(2013,5,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.16","showOnAxis":true},{"date":new Date(2013,7,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bernstein upgrades NLSN to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2013,7,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.2","showOnAxis":true},{"date":new Date(2013,8,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein downgrades NLSN to Market Perform from Outperform. Target Price is $40; previously $38.","showOnAxis":true},{"date":new Date(2013,8,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs assumes NLSN to Neutral. Target Price is $38.","showOnAxis":true},{"date":new Date(2013,9,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan assumes NLSN to Overweight. Target Price is $43.","showOnAxis":true},{"date":new Date(2013,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $41; previously $40.","showOnAxis":true},{"date":new Date(2013,9,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"FBR Capital initiates coverage on NLSN to Outperform. Target Price is $44.","showOnAxis":true},{"date":new Date(2014,1,13),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2013 Q4's earning $0.71 per share and revenue $1610MM. This beats analyst's estimated EPS $0.7, misses estimated revenue $1620MM.","showOnAxis":false},{"date":new Date(2014,1,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Wells Fargo initiates coverage on NLSN to Outperform.","showOnAxis":true},{"date":new Date(2014,1,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird initiates coverage on NLSN to Neutral. Target Price is $50.","showOnAxis":true},{"date":new Date(2014,1,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird initiates coverage on NLSN to Neutral. Target Price is $50.","showOnAxis":true},{"date":new Date(2014,1,4),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Pivotal Research upgrades NLSN to Buy from Hold. Target Price is $48.","showOnAxis":false},{"date":new Date(2014,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank assumes NLSN to Buy. Target Price is $48.","showOnAxis":true},{"date":new Date(2014,10,21),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,11,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains NLSN to Overweight. Target Price is $53; previously $52.","showOnAxis":true},{"date":new Date(2014,11,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains NLSN to Outperform. Target Price is $52; previously $56.","showOnAxis":true},{"date":new Date(2014,2,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.2","showOnAxis":true},{"date":new Date(2014,3,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $50; previously $48.","showOnAxis":true},{"date":new Date(2014,3,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains NLSN to Overweight. Target Price is $51; previously $49.","showOnAxis":true},{"date":new Date(2014,4,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays initiates coverage on NLSN to Overweight. Target Price is $55.","showOnAxis":true},{"date":new Date(2014,5,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains NLSN to Overweight. Target Price is $53; previously $51.","showOnAxis":true},{"date":new Date(2014,5,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,6,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pivotal Research downgrades NLSN to Hold from Buy.","showOnAxis":true},{"date":new Date(2014,7,26),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2014,9,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Pivotal Research upgrades NLSN to Buy from Hold. Target Price is $50; previously $48.","showOnAxis":false},{"date":new Date(2014,9,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bernstein upgrades NLSN to Outperform from Market Perform. Target Price is $49; previously $51.","showOnAxis":false},{"date":new Date(2014,9,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $46; previously $50.","showOnAxis":true},{"date":new Date(2014,9,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains NLSN to Buy. Target Price is $48; previously $52.","showOnAxis":true},{"date":new Date(2014,9,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains NLSN to Overweight. Target Price is $50; previously $55.","showOnAxis":true},{"date":new Date(2015,1,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains NLSN to Buy. Target Price is $49; previously $50.","showOnAxis":true},{"date":new Date(2015,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains NLSN to Buy. Target Price is $50; previously $51.","showOnAxis":true},{"date":new Date(2015,1,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $46; previously $47.","showOnAxis":true},{"date":new Date(2015,10,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.28","showOnAxis":true},{"date":new Date(2015,2,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.25","showOnAxis":true},{"date":new Date(2015,3,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Pivotal Research downgrades NLSN to Hold from Buy. Target Price is $49.","showOnAxis":true},{"date":new Date(2015,3,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $47; previously $46.","showOnAxis":true},{"date":new Date(2015,3,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Telsey Advisory Group initiates coverage on NLSN to Outperform. Target Price is $53.","showOnAxis":true},{"date":new Date(2015,5,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.28","showOnAxis":true},{"date":new Date(2015,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains NLSN to Overweight. Target Price is $53; previously $50.","showOnAxis":true},{"date":new Date(2015,6,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $48; previously $47.","showOnAxis":true},{"date":new Date(2015,7,10),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"BMO Capital upgrades NLSN to Outperform from Market Perform. Target Price is $53; previously $46.","showOnAxis":false},{"date":new Date(2015,7,25),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.28","showOnAxis":true},{"date":new Date(2015,8,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein maintains NLSN to Outperform. Target Price is $55; previously $54.","showOnAxis":true},{"date":new Date(2016,1,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains NLSN to Buy. Target Price is $51; previously $50.","showOnAxis":true},{"date":new Date(2016,1,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies initiates coverage on NLSN to Buy. Target Price is $58.","showOnAxis":true},{"date":new Date(2016,10,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on NLSN to Buy. Target Price is $50.","showOnAxis":true},{"date":new Date(2016,10,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on NLSN to Buy. Target Price is $50.","showOnAxis":true},{"date":new Date(2016,10,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup assumes NLSN to Neutral. Target Price is $45.","showOnAxis":true},{"date":new Date(2016,10,18),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.31","showOnAxis":true},{"date":new Date(2016,11,14),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades NLSN to Overweight from Equal-Weight.","showOnAxis":false},{"date":new Date(2016,11,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains NLSN to Overweight. Target Price is $50; previously $55.","showOnAxis":true},{"date":new Date(2016,11,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank initiates coverage on NLSN to Hold. Target Price is $48.","showOnAxis":true},{"date":new Date(2016,2,1),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.28","showOnAxis":true},{"date":new Date(2016,2,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee CRT initiates coverage on NLSN to Buy.","showOnAxis":true},{"date":new Date(2016,2,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley downgrades NLSN to Equal-Weight from Overweight. Target Price is $52.","showOnAxis":true},{"date":new Date(2016,3,20),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2016 Q1's earning $0.51 per share and revenue $1487MM. This beats analyst's estimated EPS $0.5, misses estimated revenue $1490MM.","showOnAxis":false},{"date":new Date(2016,3,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains NLSN to Buy. Target Price is $59; previously $52.","showOnAxis":true},{"date":new Date(2016,4,31),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.31","showOnAxis":true},{"date":new Date(2016,6,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital downgrades NLSN to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2016,6,26),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2016 Q2's earning $0.71 per share and revenue $1596MM. This meets analyst's estimated EPS $0.71, misses estimated revenue $1610MM.","showOnAxis":false},{"date":new Date(2016,6,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains NLSN to Overweight. Target Price is $64; previously $60.","showOnAxis":true},{"date":new Date(2016,7,23),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.31","showOnAxis":true},{"date":new Date(2016,7,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie initiates coverage on NLSN to Outperform. Target Price is $61.","showOnAxis":true},{"date":new Date(2016,8,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Cantor Fitzgerald initiates coverage on NLSN to Hold.","showOnAxis":true},{"date":new Date(2016,9,25),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, NLSN reports 2016 Q3's earning $0.74 per share and revenue $1570MM. This misses analyst's estimated EPS $0.76, misses estimated revenue $1590MM.","showOnAxis":false},{"date":new Date(2017,0,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays downgrades NLSN to Equal-Weight from Overweight.","showOnAxis":true}];